CHAD Therapeutics Inc, Chatsworth, Calif, announced that the BONSAI OXYPneumatic conserver has received official FDA 510(k) clearance. The latest innovation in conserving devices, the BONSAI is the first pneumatic conserver to offer up to a 6:1 savings ratio. Weighing just 9.9 ounces, the BONSAI conserver provides 8 flow settings, an adjustable continuous flow feature, and utilizes a single-lumen cannula.
"A pneumatic conserving device that offers a 6:1 savings ratio while ensuring adequate oxygen saturation for patients is exactly what providers need at a time when they are trying to reduce costs." said Earl Yager, President and CEO.
CHAD introduced the BONSAI at the Medtrade Expo in
Las Vegas last month. Attendees were excited about its lightweight
design and conserving ratios.
"The Bonsai demonstrates CHAD’s ongoing commitment to advanced technology that improves patient care," said Yager. "CHAD is now taking orders for the BONSAI and expects to begin shipping by the end of the month.
